MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sales of
common stock
$4,625,355
Collection of
subscriptions receivable
$1,150,000
Proceeds from exercise of
warrants
$927,000
Proceeds from borrowings
on notes payable
$500,000
Proceeds from borrowings
on notes payable -...
$175,000
Proceeds from sales of
series b convertible...
$100,000
Net cash provided by
financing activities
$7,270,855
Canceled cashflow
$206,500
End of period
$1,420,600
Canceled cashflow
$5,850,255
Repayment of borrowings on
notes payable -...
$206,500
Issuance of common stock
for services
$10,716,692
Impairment of license
agreement-Related Party
-$1,239,942
Options vested for
stock-based compensation
$1,168,280
Amortization of intangible
assets
$1,122,639
Amortization of license
agreement
$600,552
Loss from settlement
-$125,624
Operating lease right of
use asset
$68,539
Accounts payable and
accrued liabilities
$55,669
Loss from debt
extinguishment related parties
-$19,388
Payroll tax liabilities
$9,421
Depreciation
$1,012
Net cash used in
operating activities
-$5,850,255
Canceled cashflow
$15,127,758
Net loss
-$20,643,455
Other liabilities
-$216,358
Operating lease
right-of-use liabilities
-$74,046
Due from related
party-Related Party
$20,056
Deposits
-$16,957
Prepaid
expenses-Nonrelated Party
$7,021
Prepaid
expenses-Related Party
$120
Back
Back
Cash Flow
source: myfinsight.com
MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC. (MGRX)